Published in
Elsevier, European Journal of Cancer, 2(35), p. 208-213
DOI: 10.1016/s0959-8049(98)00392-x
Links
Tools
Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients1Accepted as a poster presentation to the 34th Annual Meeting of the American Society of Clinical Oncology, May 1998, Los Angeles, U.S.A.1
Journal article published in 1999 by
E. Bajetta,
N. Zilembo,
M. Dowsett,
L. Guillevin,
A. Di Leo,
L. Celio 
,
A. Martinetti,
A. Marchianò,
P. Pozzi,
S. Stani,
E. Bichisao
,
A. Martinetti,
A. Marchianò,
P. Pozzi,
S. Stani,
E. Bichisao
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 